ACP Programme Funding FY 2021 Cycle 2 - Joint Office of Academic Medicine Mar 2021 - SingHealth Duke ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ACP Programme Funding
FY 2021 Cycle 2
Joint Office of Academic Medicine
Mar 2021
Restricted, Sensitive (Normal)
1
Agenda
1. Introduction
• ACP Programme Funding (Overview)
2. FY 2021 Cycle 2 ACP Programme Funding
• Education support
• Clinical & Systems Innovation support
• Research support
• Pitch-for-Funds
• Nurturing Clinician Researcher Scheme *updated
• Global Health Support
2 Restricted, Sensitive (Normal)
ACP Programme Funding
OBJECTIVE
Programmes that will seed development and facilitate advancement of the ACPs’ Academic Medicine
strategic goals.
Introduction
Awarded based on merit to 4 areas: Education Support, Clinical & Systems Innovation Support, Research Support &
Global Health Support.
ACP-initiated (Programme must be endorsed and supported by the ACP Key Appointment Holders).
Programmes can be multi-year, up to a maximum duration of 3 years.
Schedule
Cycle 1 - Open for application in Aug 2020 (Programme commencement in Apr 2021)
Cycle 2 - Open for application in Mar 2021 (Programme commencement in Oct 2021)
Guiding
Principles ✓ Seed development of initiatives with academic merit.
✓ Deliver strong &/or strategic KPIs.
✓ Promote collaborations within the SingHealth Duke-NUS AMC &/or relevant external entities.
✓ Demonstrate financial sustainability (where appropriate).
✓ Ability to garner multi-source funding (especially in the case of a large-scale multi-collaborators strategic project).
✓ There should not be any duplication/overlap with existing platforms/resources within SingHealth Duke-NUS AMC.
3 Restricted, Sensitive (Normal)Types of Programme Funding
2. Clinical & Systems
1. Education Support To
a) Build education pipeline and educators Improve
Innovation Support
Patients’ Lives Promote clinical and systems innovation to
b) Develop sustainable educational
transform healthcare
programmes
Care to Heal
Educate Innovate to
to Empower Advance
3. Research Support 4. Global Health Support
a) Pilot and seed research programme (e.g. Pitch for fund) - Max Seed development of ACP activities in
S$40,000/year for 3 years Global Health to advance academic
b) Nurturing Clinician Researcher Scheme (NCRS) – CS, CIV and CIN medicine strategic priorities
*updated
4 Restricted, Sensitive (Normal)1. Education Support
OBJECTIVE
To encourage development of healthcare education programmes or initiatives which are sustainable
and in line with academic medicine priorities.
Introduction
A total quantum of S$500,000 p.a. or S$250,000 for award per cycle. Funding quantum for each proposal is capped at
$50,000. The duration of the project may range for a year and last up to a maximum of 3 years
✓ There should not be any duplication/overlap with existing platforms/resources within SingHealth Duke-NUS AMC
Guiding
Principles (e.g. resources from AMEI, SingHealth Academy, SingHealth Graduate Medical Education Office etc).
✓ Proposals with application potential or wider impact implementation across SingHealth will be considered more
favourably.
✓ Demonstrate financial sustainability with a viable business plan after project funding ended.
✓ Deliverables or KPIs need to be clear and measureable.
✓ Funding does not cover:
● Purchase of overseas consultancy service delivered in Singapore, and
● Overseas travel expenses (e.g. overseas conference, seminars, etc.) are not supportable.
5 Restricted, Sensitive (Normal)2. Clinical & Systems Innovation Funding Support
OBJECTIVE
To promote clinical and systems innovation to transform healthcare,
in support of SingHealth Duke-NUS AMC priorities
Introduction
A total quantum of S$800,000 p.a. or S$400,000 for award per cycle. Funding quantum for each proposal is capped at
$100,000. The duration of the project may range from a year to a maximum of 3 years.
The overarching goal of the Clinical & Systems Innovation proposals is to transform healthcare, especially in areas
Guiding
Principles pertaining to:
✓ Improvement of patient experience, clinical outcomes, and patient safety.
✓ Reduction in per capita cost of healthcare, promote quality and value-driven academic outcomes.
✓ Improvement of the overall experience of providing care, from the perspective of healthcare staff
✓ Improvement of the overall national and population health.
✓ Objective of the project should not be to start a clinical service or to enhance any existing services, which should be
funded by the healthcare institution.
Note: Overseas travel expenses (e.g. overseas conference, seminars, etc.) are not supportable.
6 Restricted, Sensitive (Normal)3. Research Support – Pitch-For-Funds
OBJECTIVE
To pilot and seed research programmes for clinicians/ non-clinicians aspiring to become future
researchers.
Introduction
Funding quantum for each Pitch-For-Funds (PFF) award is capped at $120,000 and for a duration of 3 years.
Guiding ✓ The main objective of PFF is to provide seed funding to aspiring researchers who may be able to apply for cluster or
Principles national competitive grant with preliminary data generated.
✓ PFF should be used primarily to off-set the research project expenses with an aim to generate useful data for
subsequent study.
✓ Each ACP is allowed only one (1) PFF at any period.
✓ Overlapping of PFF is not allowed and ACP should write in to JOAM with strong justification to seek approval.
Note: PFF is currently only applicable for hospital-based ACPs.
7 Restricted, Sensitive (Normal)3. Research Support – Nurturing Clinician Researcher Scheme
OBJECTIVE:
Nurture young clinicians to become successful clinician-researcher within the SingHealth Duke-NUS AMC, and to spur
them onto gaining competencies and experience to become competitive for external research grants, allowing them to
embark on a sustainable research career
[i.e. either as a Clinician Scientist (CS) or a Clinician-Investigator (CIV) or a Clinician-Innovator (CIN).]
(1) A candidate must be nominated by his or her primary ACP.
Introduction (2) In every Financial Year (FY), a total of S$2.25M will be available for NCSS awards (2 cycles per FY).
(3) The Review Panel may recommend:
(a) for a CS award – support of up to $225,000 over a tenure of up to 3 years; and
(b) for a CIV or CIN award – support of up to $150,000 over a tenure of up to 3 years.
The Review Panel may also include specific condition(s) which shall be a pre-requisite to be accepted by the shortlisted
candidate and his/her ACP to be considered for an award.
(4) This scheme is to help the awardee to gain experience and to generate pilot data in order to compete successfully for
external grant.
Criteria 1. Qualified medical doctor/ dental specialist employed to perform clinical duties in a SingHealth Institution. Holder of a PhD,
MCI or equivalent qualification is the preferred candidate.
2. On a case-by-case basis, a nursing or allied-health practitioner with a relevant PhD qualification, who performs clinical
duties and aspires to become a clinician-researcher working on human clinical research that has potential health impact may
be considered. Such a nominee must have strong support of the ACP to which the nominee is associated.
8 Restricted, Sensitive (Normal)3. Research Support – Nurturing Clinician Researcher Scheme
3. The nominee must not be a scientist or staff whose primary career commitment is to perform research.
4. After receiving the NCRS grant, the applicant must not have received funding to conduct their own research project
which cumulatively exceeds S$300,000 regardless of funding source e.g. internal, external, philanthropy or industry
etc. This is to ensure that the applicant is able to fulfil the NMRC CS-IRG-NIG criteria. *updated
Criteria
continued.. 5. For clinicians (with MBBS/MD/BDS), the maximum number of years after exiting from specialist training should not
exceed 7 years; and for a PhD holder who is applying on an exception basis, the maximum number of years of post-
doctoral experience is 7 years post PhD. [Since NMRC’s criteria is ≤10 years post specialist exit/ post PhD].
6. An application must include a Career Development Plan endorsed by the ACP Chair, which briefly outlines steps to
be taken over the immediate next 5 years to put the nominee on track to become a clinician researcher.
7. The ACP must be committed to setting aside at least 20% protected time for the awardee to perform research.
(Khoo Scholars programme and ACGME residency guidelines in terms of protected time will apply where applicable).
The associated cost shall be borne by the awardee’s host institution. *updated
8. Project for NCRS submission should encompass elements to support transition of the candidate to becoming a
proficient clinician researcher (i.e. to be able to initiate and direct his or her own line of research).
9 Restricted, Sensitive (Normal)3. Research Support – Nurturing Clinician Researcher Scheme
Deliverables
▪ The awardee is expected to apply for a national grant(1) or an external grant(2)(3) within the duration of being supported. The
awardee should continue in his/her effort to secure a national/external grant throughout the whole duration of the NCRS grant
period, and beyond if necessary. *updated
Important Notes:
(1) A CS awardee is expected to apply for a NMRC grant, preferably a talent development Award, such as a NMRC (TA), with the
viewing of working towards a CSA-INV award eventually. Failing to secure a TA or CSA-INV award, it is acceptable to attempt
applying for a NMRC-NIG award or any of the equivalent. *updated
(2) A CIV awardee is expected to apply for an external competitive grant, including that from NMRC (E.g. NIG, HSRG, or any of the
equivalent), or any other government, public, or private research funding agencies, of a quantum equal to or higher than the
NCRS award. *updated
(3) A CIN awardee is expected to apply for follow-on funding from government funding agencies (e.g. NHIC Innovation to Develop
(I2D) Grant, SMART Innovation Grant and NRF Central Gap Fund) or a NMRC grant that provide support for sustained career
development as a CIN. *updated
The awardee should demonstrate potential of their project in securing subsequent financial support from industries. In which case,
the end deliverable is the creation of a physical clinical device, diagnostic solution or medical technology etc., with the potential to
implement across the AMC and optimally across other healthcare institutions and/or commercialization. *updated
10 Restricted, Sensitive (Normal)4. Global Health Support
OBJECTIVE
To promote interest in and provide opportunities for global health projects in the region in line with
academic medicine priorities.
Introduction
A total quantum of S$300,000 p.a. or S$150,000 for award per cycle. Funding quantum for each proposal is capped at
$50,000. The duration of the project may range for a year and up to a maximum of 3 years.
✓ Seed development of Global Health projects with academic merit.
Guiding ✓ Research proposals must be for projects that are implemented in low and middle-income countries (LMICs) in Asia,
Principles
with preference given to those conducted in ASEAN countries .
✓ Education proposals can include activities within Singapore or in LMICs in Asia with preference for ASEAN countries .
✓ Proposals that are considered more favourably:
- Have application potential or wider impact implementation
- Have a sustainable line of GH research/ educational opportunities
- Results generated can be used to apply for or attract future external funding .
✓ Projects must have clear and measurable deliverables that will contribute to the advancement of knowledge and/ or
practice in academic medicine .
✓ New investigators or investigators new to GH are encouraged.
11 Restricted, Sensitive (Normal)Domain Proposal Review Panels (DPRPs)
Clinical & Systems Innovation
Education Proposal
Proposal Review Panel
Review Panel (EPRP)
(CSIPRP)
AMEI
Co-chaired by IPSQ & OOT
Research Proposal Global Health Proposal
Review Panel (RPRP) Review Panel (GHPRP)
AMRI SDGHI
Roles of DPRP:
1. Perform rigorous selection of worthy Academic Medicine initiatives to support, based on merit and criteria.
2. Help strengthen the proposals by providing domain-specific expertise on the proposed initiatives.
12 Restricted, Sensitive (Normal)ACP Programme Funding submission details
✓ Due Date for Submission – 5 May 2021 (Wednesday)
✓ Procedure:
▪ Submission must be ACP-initiated (Proposal must be endorsed and supported by the ACP Key
Appointment Holders)
▪ Submission must be made using the prescribed ACP Programme Funding Application Form. NCRS
applicants are also required to complete the NCRS Nomination Form.
▪ Submission requirements:
a. Electronic copy of the application form with endorsement; &
b. Word version of the application form
▪ Please submit your application through your respective ACP to us.
(refer to page 14 for ACP Key Administrators)
For enquiries, Lin Qiaojun (lin.qiao.jun@duke-nus.edu.sg) - OBGYN, PAEDS, FM and EM ACPs
please contact: Wong Zeng Jie (wong.zeng.jie@duke-nus.edu.sg) - SURG, EYE, NEUROSC ACPs
Joseph Ho (josephho@nus.edu.sg) - CVS, ONCO, PATH and RADSC ACPs
Tang Xue Hui (tangxuehui@duke-nus.edu.sg) – MED, ORH, ANAES and MSKSC ACPs
13 Restricted, Sensitive (Normal)ACP Key Administrators
S/N ACP Name Email Institution
Obstetrics & Gynaecology Academic Clinical Programme
1 Wong Shuxian, Julin julin.wong.sx@kkh.com.sg KKH
(OBGYN ACP)
Yong Lee Kin, Jaxii jaxii.yong.lk@kkh.com.sg
2 Paediatrics Academic Clinical Programme (PAEDS ACP) KKH
Wilson Low Cong Jin wilson.low.cj@kkh.com.sg
3 Medicine Academic Clinical Programme (MED ACP) Tan Laye Yuen, Lynn lynn.tan.l.y@sgh.com.sg SGH
4 Surgery Academic Clinical Programme (SURG ACP) Karen Chen Yi Chen karen.chen.y.c@sgh.com.sg SGH
Ophthalmology & Visual Sciences Academic Clinical Programme
5 Chia Hui Yien Chia.Hui.Yien@snec.com.sg SNEC
(EYE ACP)
6 Neuroscience Academic Clinical Programme (NEUROSC ACP) Lum Lai Lin, Jeannie Jeannie_LUM@nni.com.sg NNI
Cardiovascular Sciences Academic Clinical Programme (CVS
7 Tan Soo Hwee, Tasha tasha.tan.s.h@nhcs.com.sg NHCS
ACP)
8 Oncology Academic Clinical Programme (ONCO ACP) Nor Hafiz Hassan nor.hafiz.hassan@nccs.com.sg NCCS
9 Pathology Academic Clinical Programme (PATH ACP) Cai Huiling cai.huiling@sgh.com.sg SGH
Radiological Sciences Academic Clinical Programme (RADSC
10 Ang Choo Ping, Mindy mindy.ang.c.p@sgh.com.sg SGH
ACO)
11 Oral Health Academic Clinical Programme (ORH ACP) Dr Ng Kwang Loong, Stanley stanley.ng.k.l@ndcs.com.sg NDCS
Anaesthesiology and Perioperative Sciences Academic Clinical
12 Neoh Gaik Yie, Christine christine.neoh.g.y@sgh.com.sg SGH
Programme (ANAES ACP)
Musculoskeletal Sciences Academic Clinical Programme (MSKSC
13 Thng Suyin, Tiffany tiffany.thng.suyin@sgh.com.sg SGH
ACP)
14 Family Medicine Academic Clinical Programme (FM ACP) Quek York Tong, Eugene eugene.quek.y.t@singhealth.com.sg SHP
15 Emergency Medicine Academic Clinical Programme (EM ACP) Mae Sia mae_sia@cgh.com.sg CGH
14 Restricted, Sensitive (Normal)Thank you Restricted, Sensitive (Normal)
You can also read
